Uncategorized

Transforming Patient Outcomes – Duplicate – [#1668] August 15, 2024 According to Gramener, a Gartner-recognized company, Natural Language Processing (NLP) is projected to add $4.3 billion in revenue to the healthcare market by 2026. Clinakos Inc.‘s Medically Smart AI™ leverages NLP and Machine Learning (ML) to ignite innovation and improve patient outcomes. Our AI-driven insights […]

Transforming Healthcare with Patient360 August 8, 2024 Clinakos’ Integrated Patient Data is linked and curated from thousands of data sources from EHRs, lab results, imaging reports, SDOH, and patient-reported outcomes. This integrated approach enables a holistic Patient360 view of the patients to understand the full scope of a patient’s medical history, leading to more informed

Transforming Patient Outcomes June 18, 2024 Did you know that the UK pays up to £30,000 per QALY (Quality Adjusted Life Year) for drugs used by their patients. In the US, organizations like ICER may evaluate the value of life-saving drugs, and the reimbursements can be even higher. Organizations like ISPOR—The Professional Society for Health

Stanford University and US DOJ’s “The Promoting Competition in AI” Event May 31, 2024 Thank you Stanford University and US DOJ for inviting me to join the “The Promoting Competition in AI” event co-hosted by the U.S. Department of Justice and the Stanford Institute for Economic Policy Research, yesterday, May 30th. Event speakers & attendees

Meet us at ISPOR 2024 – Copy May 16, 2024 ISPOR24 came to a completion yesterday and completely lived up to its reputation of being the top global event for Health Economics and Outcomes Research (HEOR) professionals. The event started with the first of its kind workshop focused “Patient-Centered Research Summit 2024”. Clinakos Inc. attended

Meet us at ISPOR 2024 May 2, 2024 ISPOR—The Professional Society for Health Economics and Outcomes Research 2024 is just around the corner, set to take place in Atlanta from May 5-8, 2024. Discover how Clinakos Inc. leverages Integrated Patient Data™ and Medically Smart AI™, alongside our access to unique patient cohorts, to deliver innovative solutions

Asembia’s AXS24 Summit is coming up soon April 25, 2024 Asembia’s AXS24 Summit is coming up soon in Las Vegas from April 28 to May 2, 2024. Explore how Clinakos Inc. utilizes Integrated Patient Data™ and Medically Smart AI™, along with our access to niche patient populations to provide novel solutions for life sciences teams.

Over 2400 participants came together at Word Orphan Drug Congress USA April 17, 2024 The World Orphan Drug Congress USA unfolds today at the Boston Convention and Exhibition. With over 2,400 participants coming together, the main theme of “Breaking down silos and fostering collaboration to help rare disease patients” sets the stage for impactful discussions.

A Remarkable Gathering at AMCP 2024 in New Orleans April 22, 2024 With the wrap up of AMCP 2024 in New Orleans, we are thrilled to observe how the conference themes aligned so deeply with Clinakos Inc.‘s mission to better healthcare outcomes and patient care. The conference was a catalyst for progress and collaboration in

Leveraging AI/ML to Improve Marketing Effectiveness in Rare Disease & Beyond April 22, 2024 “Leveraging AI/ML to Improve Marketing Effectiveness in Rare Disease & Beyond” from Clinakos Inc., Chiesi Global Rare Diseases and Real Chemistry received a lot of interest at the Intellus Worldwide annual conference last week. Lisa Griffith opened the presentation with Inder